A citation-based method for searching scientific literature

Ian B Squire, Christopher P Nelson, Leong L Ng, David R Jones, Kent L Woods, Paul C Lambert. Clin Sci (Lond) 2010
Times Cited: 15







List of co-cited articles
74 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
46

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
Ann-Marie Svensson, Darren K McGuire, Putte Abrahamsson, Mikael Dellborg. Eur Heart J 2005
217
40

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Ischa Stranders, Michaela Diamant, Rogier E van Gelder, Hugo J Spruijt, Jos W R Twisk, Robert J Heine, Frans C Visser. Arch Intern Med 2004
251
33


Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
Nazneem N Wahab, Elizabeth A Cowden, Neil J Pearce, Martin J Gardner, Heather Merry, Jafna L Cox. J Am Coll Cardiol 2002
289
33

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Lan Xiao, Philip G Jones, Suzanne Fiske, Frederick A Masoudi, Steven P Marso, John A Spertus. Circulation 2008
282
33

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Prakash Deedwania, Mikhail Kosiborod, Eugene Barrett, Antonio Ceriello, William Isley, Theodore Mazzone, Philip Raskin. Circulation 2008
306
33

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Ph Gabriel Steg, Stefan K James, Dan Atar, Luigi P Badano, Carina Blömstrom-Lundqvist, Michael A Borger, Carlo Di Mario, Kenneth Dickstein, Gregory Ducrocq, Francisco Fernandez-Aviles,[...]. Eur Heart J 2012
33

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, Jose C Nicolau, Judith S Hochman, W Douglas Weaver, Pierre Theroux, Gustavo B F Oliveira, Thomas G Todaro, Christopher F Mojcik,[...]. Eur Heart J 2006
141
26

Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study.
Nitin Narayan Gholap, Rajnikant Laxmishanker Mehta, Leong Ng, Melanie J Davies, Kamlesh Khunti, Iain B Squire. BMJ Open 2012
13
30

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.
D K McGuire, H Emanuelsson, C B Granger, E Magnus Ohman, D J Moliterno, H D White, D Ardissino, J W Box, R M Califf, E J Topol. Eur Heart J 2000
128
20




Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ channels through different protein kinase C isoenzymes.
Richard D Rainbow, Robert I Norman, Diane E Everitt, Jennifer L Brignell, Noel W Davies, Nicholas B Standen. Cardiovasc Res 2009
38
20

Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.
Artur Dziewierz, Dawid Giszterowicz, Zbigniew Siudak, Tomasz Rakowski, Jacek S Dubiel, Dariusz Dudek. Clin Res Cardiol 2010
23
20


Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
Jorik R Timmer, Miriam Hoekstra, Maarten W N Nijsten, Iwan C C van der Horst, Jan Paul Ottervanger, Robbert J Slingerland, Jan-Henk E Dambrink, Henk J G Bilo, Felix Zijlstra, Arnoud W J van 't Hof. Circulation 2011
155
20

Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction.
Suzanne V Arnold, Kasia J Lipska, Yan Li, Darren K McGuire, Abhinav Goyal, John A Spertus, Mikhail Kosiborod. Am Heart J 2014
36
20

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
20

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
Shamir R Mehta, Salim Yusuf, Rafael Díaz, Jun Zhu, Prem Pais, Denis Xavier, Ernesto Paolasso, Rashid Ahmed, Changchun Xie, Khawar Kazmi,[...]. JAMA 2005
478
13

Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus.
Jie J Cao, Michael Hudson, Michelle Jankowski, Fred Whitehouse, W Douglas Weaver. Am J Cardiol 2005
74
13

Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
13

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
Leo Timmers, José P S Henriques, Dominique P V de Kleijn, J Hans Devries, Hans Kemperman, Paul Steendijk, Cees W J Verlaan, Marjolein Kerver, Jan J Piek, Pieter A Doevendans,[...]. J Am Coll Cardiol 2009
345
13

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray,[...]. Lancet 2005
13

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
Rafael Díaz, Abhinav Goyal, Shamir R Mehta, Rizwan Afzal, Denis Xavier, Prem Pais, Susan Chrolavicius, Jun Zhu, Khawar Kazmi, Lisheng Liu,[...]. JAMA 2007
132
13

Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.
Mahmoud Suleiman, Haim Hammerman, Monther Boulos, Michael R Kapeliovich, Abeer Suleiman, Yoram Agmon, Walter Markiewicz, Doron Aronson. Circulation 2005
187
13


Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, S Efendic, M Fisher, A Hamsten, J Herlitz,[...]. Eur Heart J 2005
705
13



Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry.
Oliver Schnell, Oliver Schäfer, Sonja Kleybrink, Wittich Doering, Eberhard Standl, Wolfgang Otter. Diabetes Care 2004
45
13


The Myocardial Ischaemia National Audit Project (MINAP).
Emily Herrett, Liam Smeeth, Lynne Walker, Clive Weston. Heart 2010
175
13

Universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Harvey D White. Eur Heart J 2007
13

Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Pei-Chi Chen, Su-Kiat Chua, Huei-Fong Hung, Chung-Yen Huang, Chiu-Mei Lin, Shih-Ming Lai, Yen-Ling Chen, Jun-Jack Cheng, Chiung-Zuan Chiu, Shih-Huang Lee,[...]. J Diabetes Investig 2014
20
13

Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.
Masaharu Ishihara, Sunao Kojima, Tomohiro Sakamoto, Yujiro Asada, Chuwa Tei, Kazuo Kimura, Shunichi Miyazaki, Masahiro Sonoda, Kazufumi Tsuchihashi, Masakazu Yamagishi,[...]. Am Heart J 2005
129
13

Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
Abhinav Goyal, Shamir R Mehta, Rafael Díaz, Hertzel C Gerstein, Rizwan Afzal, Denis Xavier, Lisheng Liu, Prem Pais, Salim Yusuf. Circulation 2009
87
13

Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Ignacio Cruz-Gonzalez, Stanley Chia, Owen C Raffel, Maria Sanchez-Ledesma, Fred Senatore, Frans J Wackers, David M Nathan, Ik-Kyung Jang. Diabetes Res Clin Pract 2010
17
13


Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.
Masaharu Ishihara, Eisuke Kagawa, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Yasuharu Nakama, Tatsuya Maruhashi, Keisuke Ookawa, Kazuoki Dai,[...]. Am J Cardiol 2007
92
13

U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.
Duane S Pinto, Adam H Skolnick, Ajay J Kirtane, Sabina A Murphy, Hal V Barron, Robert P Giugliano, Christopher P Cannon, Eugene Braunwald, C Michael Gibson. J Am Coll Cardiol 2005
123
13

Acute hyperglycemia abolishes ischemic preconditioning in vivo.
J R Kersten, T J Schmeling, K G Orth, P S Pagel, D C Warltier. Am J Physiol 1998
129
13

Hyperglycemia and QT interval: time for re-evaluation.
R Marfella, F Rossi, D Giugliano. Diabetes Nutr Metab 2001
21
13

Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
R D Rainbow, R I Norman, D Hudman, N W Davies, N B Standen. J Mol Cell Cardiol 2005
15
13



PKC-{epsilon}-dependent survival signals in diabetic hearts.
Ashwani Malhotra, Rebecca Begley, Barinder P S Kang, Irmindra Rana, Jing Liu, Guiping Yang, Daria Mochly-Rosen, Leonard G Meggs. Am J Physiol Heart Circ Physiol 2005
37
13

Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization.
Claudia Miele, Flora Paturzo, Raffaele Teperino, Fumio Sakane, Francesca Fiory, Francesco Oriente, Paola Ungaro, Rossella Valentino, Francesco Beguinot, Pietro Formisano. J Biol Chem 2007
51
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.